Older age, diagnostic delays, and a greater disability at diagnosis were associated with a higher risk of developing permanent disability for people with neuromyelitis optica spectrum disorder (NMOSD) at a center in Mexico. “This information is required to design healthcare strategies to recognize and treat patients with NMOSD early…
News
Age, sex, and spinal lesions may be risk factors for developing pain due to nerve damage — called neuropathic pain — in people with neuromyelitis optica spectrum disorder (NMOSD), according to a new study. Specifically, an older age at disease onset, female sex, and a greater number of lesions…
Impairments in the visual field — the total area in which objects can be seen in a person’s peripheral vision — were found in adults with optic neuritis (ON) related to neuromyelitis optica spectrum disorder (NMOSD), according to a new study. NMOSD patients with optic neuritis had more visual…
Women with neuromyelitis optica spectrum disorder (NMOSD) who received immunosuppressive treatment during pregnancy or were at least 32 years old when they conceived may be at a lower risk of pregnancy-associated relapses, a systematic review study has found. Data also showed the risk of relapse is highest in the…
SinoMab BioScience has been cleared by Chinese regulators to launch a clinical trial for its experimental immune-suppressing therapy SN1011 in people with neuromyelitis optica spectrum disorder (NMOSD). The company is anticipating that the Phase 2/3 trial will begin enrolling participants in early 2023. “The IND [investigational new drug]…
Patients with neuromyelitis optica spectrum disorder (NMOSD) or multiple sclerosis (MS), another disease that damages the protective myelin sheaths around nerve cells, are at higher risk than healthy individuals of also developing Parkinson’s disease (PD), a South Korean study found. The study, “Risk of Parkinson’s disease…
Authorities in China have granted IASO Biotherapeutics the go-ahead to begin clinical testing of the experimental CAR T-cell therapy equecabtagene autoleucel in people with neuromyelitis optica spectrum disorder (NMOSD), IASO announced. NMOSD is an autoimmune disorder wherein the body’s immune system launches an inflammatory attack that damages parts…
The CoronaVac vaccine, which contains inactivated SARS-CoV-2, the virus that causes COVID-19, led to a severe case of late-onset neuromyelitis optica spectrum disorder (NMOSD) in a 70-year-old woman. The unique case was described in an article, “Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A…
A man’s first manifestation of neuromyelitis optica spectrum disorder (NMOSD) was aseptic meningitis, an inflammation of the meninges (the membranes that enclose the brain and spinal cord) without evidence of a bacterial infection, which is unusual and made a quick diagnosis difficult, says a report from Japan. The man…
Vaccination against SARS-CoV-2, the virus that causes COVID-19, may trigger neuromyelitis optica spectrum disorder (NMOSD), a case report suggests. The report, “Antibody‐Positive Neuromyelitis Optica Spectrum Disorder After Second COVID‐19 Vaccination: a Case Report,” was published in the journal SN Comprehensive Clinical Medicine. Recommended…
Recent Posts
- 2 NMOSD drugs show equal power at preventing disease relapses
- Confessions of the kind of NMOSD patient doctors warn their interns about
- Real-world data show Enspryng reduces NMOSD relapses over 2.5 years
- How to power through each day, even if you’re living with NMOSD
- Estrogen may drive brain inflammation in NMOSD: Mouse study